Healthcare
Amgen’s Imdelltra Receives FDA Approval as Breakthrough Lung Cancer Treatment
New Therapy Offers Hope for Patients With Advanced Small-Cell Lung Cancer, Extending Survival Rates and Quality of Life The Food...
Oncocyte Announces Bio-Rad Partnership and Raises $15.8M to Accelerate Transplant Diagnostic Launch
Oncocyte's Strategic Collaboration and Financial Discipline Highlight First Quarter Achievements Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, reported key...
Cidara Therapeutics Reacquires Flu Program and Secures $240M in Private Placement
Strategic Shift Allows Cidara Therapeutics to Focus on Cloudbreak Platform for Universal Influenza Protection Cidara Therapeutics, Inc. (Nasdaq: CDTX) reported...
Novavax’s Strategic Leap in Vaccine Development
Novavax's Financial Outlook and Expedites COVID-19 and Influenza Vaccine Initiatives Novavax (NVAX), a leading vaccine developer, has announced a groundbreaking...
Advancing Cancer Therapy: CytomX’s Positive Clinical Data and Future Milestones
Insights into CytomX's Innovative Therapeutic Pipeline and Financial Performance CytomX Therapeutics (CTMX), a pioneering player in the oncology therapeutics domain,...
Market Movers: Stocks Soaring on Strong Performance and Strategic Moves
Positive Developments Propel Safe & Green Holdings, WideOpenWest, Upland Software, AXT Inc., and Tandem Diabetes Care to Impressive Gains Several...
Amgen’s Obesity Drug Excites Investors as Shares Surge
Positive Early Results Propel Amgen to Compete in Lucrative Weight-Loss Market Amgen (AMGN) experienced a significant surge in its shares...
Moderna Reports Narrower Loss Amid Decline in Covid Vaccine Sales
Biotech Company Reiterates Sales Guidance, Anticipates Launch of RSV Vaccine Moderna (MRNA), the biotech company at the forefront of Covid...
Pfizer Reports Strong Revenue and Adjusts Profit Outlook, Driven by Cost Cuts and Non-Covid Sales
Pharmaceutical Giant's Performance Signals Recovery Amid Decline in Covid Product Demand Pfizer's (PFE) first-quarter results surpassed expectations, with revenue beating...
Eli Lilly Boosts Sales Forecast as Demand Soars for Weight-Loss Drug Zepbound
Increased Manufacturing Capacity to Address Shortages and Meet Skyrocketing Demand Eli Lilly & Co. (LLY) announced a significant increase in...
